ZA873743B - Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon - Google Patents

Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Info

Publication number
ZA873743B
ZA873743B ZA873743A ZA873743A ZA873743B ZA 873743 B ZA873743 B ZA 873743B ZA 873743 A ZA873743 A ZA 873743A ZA 873743 A ZA873743 A ZA 873743A ZA 873743 B ZA873743 B ZA 873743B
Authority
ZA
South Africa
Prior art keywords
cell carcinoma
recombinant human
basal cell
intralesionally
treatment
Prior art date
Application number
ZA873743A
Other languages
English (en)
Inventor
Jay Tanner Daniel
Arnold Peets Edwin
Albert Smiles Kenneth
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of ZA873743B publication Critical patent/ZA873743B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA873743A 1986-05-27 1987-05-25 Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon ZA873743B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86664486A 1986-05-27 1986-05-27

Publications (1)

Publication Number Publication Date
ZA873743B true ZA873743B (en) 1987-11-25

Family

ID=25348060

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA873743A ZA873743B (en) 1986-05-27 1987-05-25 Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Country Status (13)

Country Link
EP (1) EP0248583B1 (de)
JP (1) JPS62289526A (de)
KR (1) KR870010871A (de)
AT (1) ATE100717T1 (de)
AU (1) AU601741B2 (de)
CA (1) CA1295243C (de)
DE (1) DE3788899T2 (de)
DK (1) DK264787A (de)
ES (1) ES2061496T3 (de)
IE (1) IE62318B1 (de)
IL (1) IL82654A0 (de)
PH (1) PH26198A (de)
ZA (1) ZA873743B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
EP0278715A3 (de) * 1987-02-09 1989-03-08 Schering Corporation Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen
EP0372809B1 (de) * 1988-12-01 1993-08-04 Schering Corporation Arzneimittel zur Intralesionsbehandlung von schuppenartigem Zellkarzinomen mit rekombinantem human-alpha-Interferon
US5256410A (en) * 1988-12-01 1993-10-26 Schering Corporation Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
IL100415A0 (en) * 1990-12-21 1992-09-06 Schering Corp Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
AU2018246292A1 (en) * 2017-03-31 2019-10-10 Accanis Biotech F&E Gmbh & Co Kg Prevention and treatment of non-melanoma skin cancer (NMSC)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
AU1153083A (en) * 1982-01-15 1983-07-28 Cetus Corporation Interferon-alpha 54
EP0098864A1 (de) * 1982-01-15 1984-01-25 Cetus Corporation Interferon-alpha 74
US5098703A (en) * 1982-01-15 1992-03-24 Cetus Corporation Interferon-alpha 76
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex

Also Published As

Publication number Publication date
EP0248583B1 (de) 1994-01-26
IE62318B1 (en) 1995-01-25
AU7336687A (en) 1987-12-03
DK264787A (da) 1987-11-28
DE3788899T2 (de) 1994-05-05
EP0248583A3 (en) 1989-10-18
KR870010871A (ko) 1987-12-18
IE871358L (en) 1987-11-27
EP0248583A2 (de) 1987-12-09
IL82654A0 (en) 1987-11-30
CA1295243C (en) 1992-02-04
PH26198A (en) 1992-03-18
DE3788899D1 (de) 1994-03-10
JPS62289526A (ja) 1987-12-16
ATE100717T1 (de) 1994-02-15
AU601741B2 (en) 1990-09-20
ES2061496T3 (es) 1994-12-16
DK264787D0 (da) 1987-05-25

Similar Documents

Publication Publication Date Title
NZ212632A (en) Tumor necrosis factor, its preparation and its use
DK0433827T3 (da) Cytotoksisk lumfocytmodningsfaktor
IT1183181B (it) Derivati del 3-metil-imidazo(4,5-c)pirazolo con attivita' terapeutica e procedimento per la loropreparazione
IL102346A0 (en) Cysteine depleted il-6 muteins
NZ227944A (en) Synergistic pharmaceutical composition of a hybrid interferon and a muramylpeptide
IL82654A0 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DK0643973T3 (da) Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
ES2115582T3 (es) Preparacion y aplicaciones de interferon-gamma.
ZA884262B (en) Pharmaceutical composition for the treatment of tumors
IL92495A0 (en) Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
IL84080A0 (en) Human leukocyte interferon compositions for skin treatment
GR3006999T3 (de)
EP0278715A3 (de) Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen
HU900202D0 (en) Process for manufacturing of pharmaceutical compositions comprising gamma-interferon suitable to treatment of ovarion cancer
GR3003132T3 (en) Pharmaceutical compositions having healing activity